Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities
Simple Summary Erythropoietin (EPO) is best known as the hormone that stimulates red blood cell production and is used to treat selected forms of anemia. Cancer-related EPO biology is broader and more context-dependent. Recent studies show that tumor-derived EPO can reprogram macrophages and dendritic cells, while stre...